pharmaphorum
AUGUST 24, 2020
SMi Reports: SMi Group have made the decision due to travel restrictions to open the conference and workshops to all microbiologists by transforming it into a virtual-remote online access event only on October 28 and 29 2020. Workshop B- Mycoplasma testing by anyone, anywhere and anytime! Workshops: October 30th, 2020.
pharmaphorum
JANUARY 13, 2022
The algorithm looks at the structure of the SARS-CoV-2 spike protein used to gain entry to host cells, looking for changes that could enable the virus to evade immunity, as well as other features that could affect the ‘fitness’ of the virus – its ability to reproduce and transmit between people.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
NOVEMBER 15, 2021
Plus 2 add on workshops: • Elucidating the anti-tumor immunity of other immune checkpoint inhibitors in oncology. Ensure your research team secures its place at the forefront of the immune checkpoint inhibitor space by putting this event on the calendar for 2021. . • Utilizing biomarkers to maximize the clinical effect.
pharmaphorum
OCTOBER 12, 2020
In addition to the agenda, there will be two pre-conference interactive workshops on: Workshop A – 08.30 – 12.30 on How to Develop Physiologically Relevant Immune Competent Models in MPS, led by Pelin Candarlioglu, Investigator – Bioengineer/Cell Biologist, GSK. Workshop B – 13.30 – 17.30 — ENDS –.
pharmaphorum
APRIL 6, 2021
Modulate the immune system to drive efficacy via co-stimulatory targets to drive efficacy in solid tumors with Xencor, Harbour Biomed, Crescendo Biologics, Pieres, and Aptevo. Join our exclusive pre-conference workshop hosted by MacroGenics focused on ‘ Risk Mitigation in Translation & Clinical Development of Cell Engagers ’.
The FDA Law Blog
MARCH 13, 2023
To further expand patient input into product development, the FDA’s Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products or “OTP” (formerly the Office of Tissues and Advanced Therapies, or “OTAT”) is holding a free public workshop titled, Clinical Trials: The Patient Experience.
The FDA Law Blog
APRIL 8, 2024
It also noted that last year, FDA hosted a two-day public workshop and published a white paper on the regulatory framework for Artificial Intelligence in drug manufacturing, in addition to other efforts. This strikes us as another signal that FDA sees the policies of cGMP as evergreen, and largely immune to even seismic technology shifts.
Expert insights. Personalized for you.
52 
Let's personalize your content